Related Experiment Video
Updated: Jan 13, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Yoga for Opioid Withdrawal and Autonomic Regulation: A Randomized Clinical Trial.
Suddala Goutham1, Hemant Bhargav1, Bharath Holla1
1Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Yoga significantly speeds up opioid withdrawal recovery and improves autonomic regulation, anxiety, sleep, and pain. This adjuvant therapy offers a neurobiologically informed approach to enhance patient outcomes.
Area of Science:
- Integrative medicine
- Neuroscience
- Addiction medicine
Background:
- Opioid withdrawal is characterized by sympathetic hyperactivity and reduced parasympathetic tone, often inadequately addressed by standard treatments, leading to relapse.
- Standard pharmacological interventions may not fully restore autonomic balance during opioid withdrawal.
Purpose of the Study:
- To investigate yoga as an adjuvant therapy to accelerate opioid withdrawal recovery.
- To assess yoga's impact on heart rate variability, anxiety, sleep, and pain in individuals undergoing opioid withdrawal.
Main Methods:
- A 2-arm randomized clinical trial involving 59 adults with mild to moderate opioid withdrawal symptoms.
- Participants received standard buprenorphine treatment, with the intervention group also undertaking 10 supervised yoga sessions over 14 days.
- Co-primary outcomes included time to withdrawal stabilization and heart rate variability; secondary outcomes included anxiety, sleep latency, and pain.
Main Results:
- The yoga group demonstrated significantly faster withdrawal stabilization (median 5 days vs. 9 days) compared to the control group (HR, 4.40; P < .001).
- Yoga intervention led to superior improvements in heart rate variability (low frequency, high frequency, and LF/HF ratio; P < .001) and significant reductions in anxiety (P < .001).
- Improvements in parasympathetic activity mediated 23% of the treatment effect, with significant benefits observed in sleep latency and pain.
Conclusions:
- Yoga as an adjuvant therapy significantly accelerates opioid withdrawal recovery.
- Yoga improves autonomic regulation, reduces anxiety, and alleviates pain and sleep disturbances in individuals with opioid use disorder.
- Findings support the integration of yoga into opioid withdrawal protocols as a complementary intervention targeting core regulatory processes.
More Related Videos
07:56Resting-State Connectivity and Neuroimaging of Prefrontal Cortex Activity During a Block-Design Yoga Asana Practice Using fNIRS
Published on: June 24, 2025
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
Related Concept Videos
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Drugs for Treatment of Constipation-Predominant IBS
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...